carmustine has been researched along with Eosinophilia in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although carmustine (Gliadel) wafers improve local tumor control and extend the overall survival in patients with malignant glioma, adverse effects have been documented." | 3.85 | Eosinophilic meningitis triggered by implanted Gliadel wafers: case report. ( Ivanova, A; Saito, K; Sato, Y; Takeishi, G; Takeshima, H; Yamasaki, K; Yokogami, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, K | 1 |
| Yamasaki, K | 1 |
| Yokogami, K | 1 |
| Ivanova, A | 1 |
| Takeishi, G | 1 |
| Sato, Y | 1 |
| Takeshima, H | 1 |
1 other study available for carmustine and Eosinophilia
| Article | Year |
|---|---|
Eosinophilic meningitis triggered by implanted Gliadel wafers: case report.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Carmustine; Decanoic Acids; Drug Delivery Systems; Dr | 2017 |